GO:0061135 endopeptidase regulator activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061135 endopeptidase regulator activity describes any molecular function that binds to and modulates the activity of a peptidase, an enzyme that hydrolyzes nonterminal peptide bonds in polypeptides.
• This activity is essential for controlling proteolytic cascades in processes such as mitochondrial stress responses, exercise-induced cognitive benefits, and cardiovascular protection.
• Key regulators include cathepsin B, which is released from muscle during exercise and supports cognitive function, and ATF4, which orchestrates the mitochondrial stress response by regulating peptidase activity.
• Dysregulation of endopeptidase regulators is linked to atherosclerosis, cerebral ischemia, and cancer, making them attractive therapeutic targets.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of endopeptidase regulator function in disease contexts.
• Understanding endopeptidase regulator activity provides mechanistic insights for developing therapies that modulate proteolysis in neurodegeneration, cardiovascular disease, and oncology.
Description
Endopeptidase regulator activity (GO:0061135) is a molecular function defined as binding to and modulating the activity of a peptidase, any enzyme that hydrolyzes nonterminal peptide bonds in polypeptides. This activity is fundamental to controlling proteolytic processes that would otherwise be indiscriminate, ensuring that peptide bond cleavage occurs at the right time, place, and substrate. Researchers study this term because endopeptidase regulators are central to diverse physiological and pathological pathways, from mitochondrial stress adaptation to exercise-induced cognitive enhancement. For example, cathepsin B, a lysosomal peptidase, is released from muscle during exercise and acts as a myokine that supports cognitive functions, highlighting how endopeptidase regulation bridges peripheral metabolism and brain health. Similarly, the integrated stress response transcription factor ATF4 regulates the expression of multiple peptidases and their inhibitors to maintain mitochondrial homeostasis under stress. These examples underscore the broad relevance of GO:0061135 in cell biology and disease. In this article, we synthesize authoritative QuickGO annotations and verified PubMed literature to provide a comprehensive overview of endopeptidase regulator activity, its key genes, regulatory mechanisms, disease associations, and cutting-edge research methods including CRISPR-based models.
endopeptidase regulator activity At A Glance
| GO ID | GO:0061135 |
|---|---|
| GO term | endopeptidase regulator activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binds to and modulates the activity of a peptidase, any enzyme that hydrolyzes nonterminal peptide bonds in polypeptides. |
| Major function | Regulation of proteolytic activity by direct binding to endopeptidases, either enhancing or inhibiting their catalytic function. |
| Child terms | Includes endopeptidase inhibitor activity (GO:0004866) and endopeptidase activator activity (GO:0061134). |
| Related terms | Peptidase regulator activity (GO:0061134), endopeptidase activity (GO:0004175). |
| Taxonomic range | Present in all domains of life, from prokaryotes to eukaryotes. |
What Is GO:0061135?
According to the Gene Ontology, endopeptidase regulator activity (GO:0061135) is a molecular function that encompasses any gene product that binds to and modulates the activity of a peptidase, which is any enzyme that hydrolyzes nonterminal peptide bonds in polypeptides. This definition captures both positive and negative regulation, meaning that an endopeptidase regulator can enhance or inhibit the catalytic activity of its target peptidase. The term is distinct from endopeptidase activity itself (GO:0004175) and from endopeptidase inhibitor activity (GO:0004866), which is a more specific child term. Regulators may act by stabilizing the active conformation of the peptidase, blocking its active site, altering its substrate specificity, or affecting its localization or stability. The QuickGO definition emphasizes binding as a prerequisite for modulation, indicating a direct physical interaction between the regulator and the peptidase. This functional classification is critical for annotating gene products that do not themselves cleave peptide bonds but instead control those that do.
Why Is endopeptidase regulator activity Important in Cell Biology?
Endopeptidase regulator activity is critically important because it governs the precision of proteolysis, a process that underlies virtually every aspect of cellular physiology. Without regulators, endopeptidases could degrade essential proteins indiscriminately, leading to cellular dysfunction. Regulators ensure that proteolytic events are spatially and temporally controlled, which is essential for processes such as apoptosis, immune response, tissue remodeling, and signal transduction. Moreover, dysregulation of endopeptidase regulators is implicated in a wide range of human diseases, including cancer, neurodegeneration, cardiovascular disorders, and metabolic syndromes. For instance, matrix metalloproteinase 12 (MMP12) is an endopeptidase whose activity is regulated in microglia and contributes to cerebral ischemia injury, and its downregulation by exercise is protective. Similarly, PCSK9 is a peptidase regulator that influences endothelial function and atherosclerosis, and its inhibition is a therapeutic strategy. Thus, understanding GO:0061135 is essential for both basic biology and translational medicine.
• Controls proteolytic cascades to prevent unintended protein degradation.
• Regulates key signaling pathways such as the integrated stress response and mitochondrial homeostasis.
• Modulates exercise-induced cognitive benefits through cathepsin B release.
• Influences cardiovascular health by regulating PCSK9 and endothelial function.
• Plays a role in cerebral ischemia by regulating MMP12 activity in microglia.
• Is implicated in cancer through regulators like site-1 protease and SAGA complex components.
• Provides targets for therapeutic intervention in atherosclerosis and metabolic disorders.
• Essential for proper muscle function via regulation of SERCA by endopeptidase cleavage.
• Contributes to multiorgan protection mediated by irisin, which involves peptidase regulation.
• Enables precise experimental dissection using CRISPR knockout and knock-in models.
What Happens During endopeptidase regulator activity?
Binding to the target endopeptidase
In simple terms: The regulator protein physically attaches to the endopeptidase enzyme.
The first step in endopeptidase regulator activity is the direct binding of the regulator to its target peptidase. This interaction is typically non-covalent and involves specific structural motifs that recognize the peptidase's surface or active site. For example, cathepsin B, a lysosomal cysteine protease, is regulated by endogenous inhibitors such as cystatin C, which binds to its active site cleft. Similarly, ATF4 regulates the expression of multiple peptidases and their inhibitors, indirectly affecting their activity. The binding event is crucial because it positions the regulator to modulate the peptidase's function, either by blocking substrate access or by inducing conformational changes.
Modulation of catalytic activity
In simple terms: Once bound, the regulator changes how well the endopeptidase can cut other proteins.
Upon binding, the regulator can either enhance or inhibit the catalytic activity of the endopeptidase. Inhibitory regulators often occlude the active site or distort the catalytic residues, while activators may stabilize a productive conformation or promote substrate binding. For instance, site-1 protease (S1P) is a negative regulator of sarcolipin promoter activity, illustrating how a peptidase can modulate gene expression. In the context of exercise, cathepsin B is released from muscle and acts as a myokine, but its proteolytic activity is tightly controlled by regulators to prevent tissue damage. The modulation can be reversible or irreversible, depending on the regulator.
Downstream signaling and physiological effects
In simple terms: The regulated cleavage triggers signals that affect cell behavior and body functions.
The ultimate outcome of endopeptidase regulator activity is the controlled proteolysis of specific substrates, which in turn activates or deactivates downstream signaling pathways. For example, the regulation of MMP12 by microglia polarization influences cerebral ischemia injury, where downregulation of MMP12 is protective. Similarly, PCSK9 inhibition improves endothelial function in atherosclerosis, demonstrating how regulating a peptidase can have systemic cardiovascular benefits. In muscle, endopeptidase cleavage controls the expression of a micropeptide that regulates SERCA, affecting calcium handling and muscle contractility. These examples highlight the diverse physiological consequences of endopeptidase regulation.
Integration with cellular stress responses
In simple terms: Cells use endopeptidase regulators to respond to stress and maintain balance.
Endopeptidase regulator activity is often integrated with cellular stress response pathways. ATF4, a key regulator of the mitochondrial stress response, controls the expression of numerous genes including peptidases and their regulators, thereby coordinating proteostasis under stress. This integration ensures that proteolytic activities are adjusted according to the cell's metabolic state. In cancer, disruption of the SAGA core complex triggers collateral degradation of KAT2A, a process that may involve endopeptidase regulators. Thus, endopeptidase regulators serve as critical nodes linking proteolysis to stress adaptation and disease.
Key Genes Involved in GO:0061135 endopeptidase regulator activity
The following genes encode proteins with endopeptidase regulator activity or are directly involved in regulating endopeptidases, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CTSB | Cathepsin B, a lysosomal peptidase regulated by inhibitors; released during exercise | Exercise-induced cognitive benefits; myokine signaling |
| ATF4 | Transcription factor regulating mitochondrial stress response including peptidase expression | Integrated stress response; mitochondrial homeostasis |
| MBTPS1 | Site-1 protease, a negative regulator of sarcolipin promoter activity | Muscle calcium handling; cardiovascular biology |
| MMP12 | Matrix metalloproteinase 12, regulated in microglia; involved in cerebral ischemia | Neuroinflammation; stroke |
| PCSK9 | Proprotein convertase subtilisin/kexin type 9, regulates LDL receptor; inhibited in atherosclerosis | Cardiovascular disease; lipid metabolism |
| SERCA | Sarcoplasmic/endoplasmic reticulum calcium ATPase, regulated by endopeptidase cleavage of a micropeptide | Muscle contractility; calcium signaling |
| FNDC5 | Irisin precursor, involved in multiorgan protection; may interact with peptidase regulators | Metabolism; exercise |
| KAT2A | Lysine acetyltransferase 2A, degraded upon SAGA core disruption | Chromatin regulation; cancer |
| CST3 | Cystatin C, an endogenous inhibitor of cathepsin B | Neurodegeneration; renal function |
| SERPINA1 | Alpha-1 antitrypsin, inhibits neutrophil elastase | Pulmonary disease; liver disease |
| TIMP1 | Tissue inhibitor of metalloproteinases 1, regulates MMPs | Cancer; fibrosis |
| SERPINE1 | Plasminogen activator inhibitor-1, regulates plasminogen activators | Thrombosis; cancer |
| BACE1 | Beta-secretase 1, regulated by inhibitors; involved in amyloid precursor protein cleavage | Alzheimer's disease |
| CASP3 | Caspase 3, regulated by IAP proteins; executes apoptosis | Apoptosis; cancer |
| PSEN1 | Presenilin 1, catalytic subunit of gamma-secretase; regulated by gamma-secretase modulators | Alzheimer's disease |
| ADAM17 | ADAM metallopeptidase domain 17, regulated by TIMPs; sheds TNF-alpha | Inflammation; cancer |
| MMP2 | Matrix metalloproteinase 2, regulated by TIMPs; degrades extracellular matrix | Cancer invasion; angiogenesis |
How Is endopeptidase regulator activity Regulated?
Endopeptidase regulator activity is itself subject to multiple layers of regulation. At the transcriptional level, factors such as ATF4 control the expression of both peptidases and their regulators in response to mitochondrial stress. Post-translationally, the activity of regulators can be modulated by phosphorylation, ubiquitination, or proteolytic processing. For example, the SAGA complex disruption leads to collateral degradation of KAT2A, suggesting that endopeptidase regulators are involved in protein quality control. Additionally, exercise induces the release of cathepsin B from muscle, which is then regulated in the circulation by inhibitors such as cystatin C. In cardiovascular contexts, PCSK9 expression is regulated by statins and other lipid-lowering agents, affecting its ability to modulate LDL receptor degradation. These regulatory mechanisms ensure that endopeptidase activity is finely tuned to physiological demands.
endopeptidase regulator activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PCSK9 | Atherosclerosis, hypercholesterolemia | Knockout mouse, overexpression in hepatocytes |
| MMP12 | Cerebral ischemia, neuroinflammation | Microglia-specific knockout, treadmill exercise model |
| CTSB | Cognitive decline, neurodegeneration | Muscle-specific knockout, exercise intervention |
| ATF4 | Mitochondrial stress, metabolic disorders | Inducible knockout, multi-omics analysis |
| KAT2A | Cancer, chromatin dysregulation | SAGA core disruption, degradation models |
Endopeptidase regulators in cardiovascular disease
Endopeptidase regulator activity is critically involved in cardiovascular health. PCSK9 is a secreted peptidase that regulates LDL receptor levels; its inhibition by monoclonal antibodies or CRISPR-based editing reduces atherosclerosis. In early atherosclerotic mice, high-intensity interval training and moderate-intensity continuous training mitigate endothelial dysfunction via PCSK9 inhibition. Similarly, MMP12, a matrix metalloproteinase regulated in microglia, contributes to cerebral ischemia injury, and its downregulation by treadmill exercise is protective. These findings highlight the therapeutic potential of targeting endopeptidase regulators in cardiovascular and cerebrovascular diseases.
Endopeptidase regulators in neurodegeneration and cognitive function
Cathepsin B, a lysosomal endopeptidase, is released from muscle during exercise and supports cognitive functions, as shown in a systematic review. This myokine crosses the blood-brain barrier and may influence neurogenesis and synaptic plasticity. Dysregulation of cathepsin B and its inhibitors, such as cystatin C, has been implicated in neurodegenerative diseases including Alzheimer's disease. Additionally, BACE1 and presenilin 1, both endopeptidases involved in amyloid precursor protein processing, are regulated by endogenous inhibitors and modulators, making them targets for Alzheimer's therapy. Thus, endopeptidase regulator activity is central to brain health and disease.
Endopeptidase regulators in cancer
In cancer, endopeptidase regulators influence tumor progression, invasion, and metastasis. Matrix metalloproteinases such as MMP2 and MMP12 are regulated by tissue inhibitors of metalloproteinases (TIMPs), and an imbalance in this regulation promotes extracellular matrix degradation and metastasis. Disruption of the SAGA core complex triggers collateral degradation of KAT2A, a chromatin modifier, linking endopeptidase regulation to epigenetic control in cancer. Furthermore, site-1 protease acts as a negative regulator of sarcolipin promoter activity, and its dysregulation may affect muscle and cancer biology. These examples underscore the broad impact of endopeptidase regulators in oncology.
Endopeptidase regulators in metabolic and muscle disorders
Endopeptidase cleavage controls the expression of a micropeptide that regulates SERCA, a calcium pump critical for muscle contraction and metabolism. Dysregulation of this process can lead to muscle dysfunction and metabolic disorders. Irisin, a myokine derived from FNDC5, provides multiorgan protection and may interact with peptidase regulators to modulate metabolic homeostasis. Additionally, ATF4 regulates the mitochondrial stress response, which is important for metabolic adaptation in conditions such as obesity and diabetes. Therefore, endopeptidase regulator activity is a key player in metabolic and muscle physiology.
From endopeptidase regulator activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of endopeptidase regulator X affect substrate cleavage? | CRISPR knockout cell line or mouse model |
| Does a point mutation in the regulator alter its binding to the peptidase? | CRISPR point mutation knock-in (e.g., catalytic residue mutation) |
| Can a tagged version of the regulator be used to study localization? | Knock-in of fluorescent or affinity tag (e.g., GFP, HA) |
| Does overexpression of the regulator protect against disease? | Transgenic overexpression or viral delivery |
| Which genes are essential for endopeptidase regulator activity? | Genome-wide CRISPR library screening |
| What are the downstream signaling changes upon regulator modulation? | RNA-seq, proteomics, phosphoproteomics |
How to Study the endopeptidase regulator activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function phenotypes for all genes | Identify novel endopeptidase regulators |
| AP-MS | Protein-protein interactions | Map regulator-peptidase complexes |
| Activity-based probes | Active peptidase levels | Measure cathepsin B activity in muscle |
| RNA-seq | Transcriptional changes | Assess ATF4-dependent gene expression |
| Proteomics | Protein abundance and modifications | Quantify KAT2A degradation upon SAGA disruption |
| Fluorogenic assays | Enzymatic activity kinetics | Test regulator effect on MMP12 activity |
| BioID | Proximity-dependent biotinylation | Identify transient interactions in living cells |
| Multi-omics integration | Combined transcriptome, proteome, metabolome | Systems-level analysis of stress response |
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate endopeptidase regulator activity. For example, a screen for regulators of PCSK9 secretion could reveal novel components of the secretory pathway. Similarly, screens for resistance to proteotoxic stress can uncover regulators of ATF4-dependent peptidase expression. These unbiased approaches are powerful for discovering new players in endopeptidase regulation.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can identify proteins that bind to endopeptidases, thereby defining the regulator interactome. For instance, AP-MS of cathepsin B could reveal its endogenous inhibitors and interacting partners. Proximity labeling techniques such as BioID can capture transient interactions in living cells. These methods are essential for mapping the physical interactions that underlie GO:0061135.
Activity-based probes and enzymatic assays
Activity-based probes (ABPs) are chemical tools that covalently label active peptidases, allowing researchers to measure their activity in complex samples. For example, ABPs for cathepsins can assess the impact of regulators on cathepsin B activity in muscle extracts. Fluorogenic peptide substrates are also widely used to monitor endopeptidase activity in real time, enabling kinetic analysis of regulator effects.
Transcriptomics and multi-omics
RNA sequencing and multi-omics analyses can reveal how endopeptidase regulators are transcriptionally regulated and how they impact global gene expression. For example, multi-omics analysis identified ATF4 as a key regulator of the mitochondrial stress response, including peptidase genes. Integrating transcriptomics with proteomics and metabolomics provides a systems-level view of endopeptidase regulation in health and disease.
How CRISPR Can Be Used to Study GO:0061135 endopeptidase regulator activity
Knockout
CRISPR knockout (KO) of an endopeptidase regulator gene abolishes its function, allowing researchers to observe the consequences on substrate cleavage and downstream phenotypes. For example, KO of PCSK9 in mice leads to increased LDL receptor levels and reduced atherosclerosis. Similarly, KO of cathepsin B in muscle would impair exercise-induced cognitive benefits. KO models are essential for establishing causality.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to dissect the functional domains of endopeptidase regulators. For instance, mutating the active site of a regulator that binds to a peptidase can distinguish between binding and modulation. Point mutations in ATF4 phosphorylation sites can reveal how its activity is controlled under stress. This approach provides fine-grained mechanistic insights.
Knock-in
CRISPR knock-in can insert tags (e.g., GFP, HA) or reporter genes into the endogenous locus of an endopeptidase regulator, enabling real-time tracking of its expression and localization. Knock-in of a fluorescent tag into the CTSB locus would allow visualization of cathepsin B release from muscle during exercise. Knock-in models are also useful for studying disease-associated mutations.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can increase the levels of an endopeptidase regulator to study gain-of-function effects. Overexpression of PCSK9 in hepatocytes reduces LDL receptor levels, mimicking hypercholesterolemia. Overexpression of ATF4 can protect against mitochondrial stress. These models are valuable for testing therapeutic hypotheses.
How EDITGENE Supports endopeptidase regulator activity Research
Researchers studying endopeptidase regulator activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE provides a comprehensive suite of services to generate such models efficiently, enabling mechanistic studies and therapeutic target validation.
Contact EDITGENE today to design your custom CRISPR model for endopeptidase regulator activity research.
Frequently Asked Questions About endopeptidase regulator activity
What is endopeptidase regulator activity?
Endopeptidase regulator activity (GO:0061135) is a molecular function where a protein binds to and modulates the activity of a peptidase, an enzyme that cleaves nonterminal peptide bonds in polypeptides.
What genes are involved in endopeptidase regulator activity?
Key genes include CTSB, ATF4, MBTPS1, MMP12, PCSK9, and others that encode proteins regulating peptidase activity.
How is endopeptidase regulator activity regulated?
It is regulated at multiple levels, including transcription by ATF4, post-translational modifications, and interaction with inhibitors such as cystatins.
What diseases are associated with endopeptidase regulator activity?
Dysregulation is linked to cardiovascular disease, neurodegeneration, cancer, and metabolic disorders.
What research methods are used to study endopeptidase regulator activity?
Common methods include CRISPR screens, activity-based probes, proteomics, and RNA-seq.
How can CRISPR be used to study endopeptidase regulator activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of regulator genes to study their function.
What is the role of cathepsin B in exercise and cognition?
Cathepsin B is released from muscle during exercise and acts as a myokine that supports cognitive functions, as shown in a systematic review.
How does PCSK9 regulate cholesterol?
PCSK9 binds to LDL receptors and promotes their degradation; inhibiting PCSK9 increases LDL receptor levels and lowers cholesterol.
What is the connection between endopeptidase regulators and cancer?
Regulators such as TIMPs control matrix metalloproteinases, and their imbalance promotes tumor invasion and metastasis.
Can endopeptidase regulator activity be targeted therapeutically?
Yes, PCSK9 inhibitors are already used clinically, and other regulators are being explored for cancer and neurodegeneration.
Conclusion
Endopeptidase regulator activity (GO:0061135) is a fundamental molecular function that ensures proteolysis is precisely controlled in time and space. From exercise-induced cognitive benefits mediated by cathepsin B to cardiovascular protection through PCSK9 inhibition, the breadth of its physiological and pathological roles is remarkable. Dysregulation of these regulators contributes to cancer, neurodegeneration, and metabolic diseases, making them attractive therapeutic targets. Advances in CRISPR-based models and multi-omics technologies are accelerating the discovery of new regulators and their mechanisms. EDITGENE is committed to supporting this research with state-of-the-art gene editing and bioinformatics services, empowering scientists to unravel the complexities of endopeptidase regulation.
References
- 1. Gökçe E et al.. 2023. The Relationship Between Exercise, Cathepsin B, and Cognitive Functions: Systematic Review.. Percept Mot Skills 130(4):1366-1385 PMID: 37202717
- 2. Quirós PM et al.. 2017. Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals.. J Cell Biol 216(7):2027-2045 PMID: 28566324
- 3. Sharma I et al.. 2025. Site-1 protease is a negative regulator of sarcolipin promoter activity.. Commun Biol 8(1):1351 PMID: 40993245
- 4. Zhang S et al.. 2024. Treadmill exercise improves cerebral ischemia injury by regulating microglia polarization via downregulation of MMP12.. Int Immunopharmacol 142(Pt B):113210 PMID: 39340990
- 5. Liu G et al.. 2025. HIIT and MICT mitigate endothelial dysfunction in early atherosclerotic mice via PCSK9 inhibition.. Sci Rep 15(1):30411 PMID: 40830352
- 6. Phillips TA et al.. 2022. Regulation of the regulator: Endopeptidase cleavage controls the expression of a micropeptide that regulates SERCA.. Cell Calcium 107:102655 PMID: 36179466
- 7. Ma J et al.. 2021. The role of Irisin in multiorgan protection.. Mol Biol Rep 48(1):763-772 PMID: 33389537
- 8. Batty P et al.. 2026. Disruption of the SAGA CORE triggers collateral degradation of KAT2A.. Nat Commun 17(1) PMID: 42009663
